MedPath

Paclinano

Brand Name: Paclinano

Generic Name: Paclitaxel

Active
Registration Number

DRP-15243

Dosage Form

Lyophilized Powder for Suspension for IV Infusion (Protein-bound particles)

Issuance Date

May 31, 2024

Expiry Date

May 31, 2029

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength100 mg
Packaging50-mL capacity USP Type I Clear and colorless glass vial with grey bromobutyl rubber stopper with aluminum seal and colorless flip-off cap (Box of 1's)

Classification

C
Classification
Prescription Drug (Rx)
P
Pharmacologic
Antineoplastic (Taxane)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

PaclitaxelActive
Monograph: Paclitaxel

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.